It’s interesting to note that while the Aetna-Humana merger and its subsequent denial by federal regulators received attention, a second merger, one that impacts more patients, is receiving little notice.
Not that long ago a district court judge ruled that a merger between Cigna and Blue Cross would harm competition, hurt consumers, and actually hurt Cigna’s value. Just a few days later, the current administration nominated former Anthem lobbyist, Makan Delrahim to head the antitrust division of the Department of Justice.
This is more than putting the fox in charge of the hen house. Makan lobbied quite successfully on behalf of Blue Cross in the past. There’s no reason to believe he wouldn’t continue to do so.
What does Blue Cross want? A merger with Cigna.
In fact, in court, Anthem’s lawyer told the judge that the merger stands a chance under a new DOJ and that the vice president supported the merger when he was the governor of California.
And who would pay if this merger goes through? You.
What would the government do to protect you, the patient? Nothing.